Do nicotine inhaler increase smoking cessation during pregnancy?
Knowledge Commons (Lakehead University) · 06.04.2026
DOI: 10.17613/cb6bd-fn155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Knowledge Commons (Lakehead University), erschienen am 06.04.2026. Verfasst von Steffen Mickenautsch.
Abstract (Originalsprache)
Objective
To test whether selection bias has affected the reported effect estimate for the use of nicotine inhalers (RD 0.01. 95%CI: -0.05 to 0.08), regarding smoking cessation during pregnancy.
Method
Trial adjusted, simulated comparator trial (SCT) based I2 test for single randomised controlled trials Result: The estimated selection bias level (B%) of 40% suggests that 31-40% (43 – 55 of 137) of the total trial subjects were non-randomly allocated in favour of one treatment group above the other. This level appears high enough in order to have affected the reported effect estimate.
Conclusion
The effect estimate reported by the tested trial suggests a non-significantly higher smoking cessation rate in the nicotine inhaler group during pregnancy in comparison to placebo. The selection bias level, estimated by use of the trial adjusted, simulated comparator trial (SCT) based I2 test for single RCTs, B% = 40%, appears high enough in order to have affected the reported estimate.
Schlagwörter
Zitieren
APA
Mickenautsch, S. (2026). Do nicotine inhaler increase smoking cessation during pregnancy?. Knowledge Commons (Lakehead University). https://doi.org/10.17613/cb6bd-fn155
Vancouver
Mickenautsch S. Do nicotine inhaler increase smoking cessation during pregnancy?. Knowledge Commons (Lakehead University). 2026. doi:10.17613/cb6bd-fn155
BibTeX
@article{Mickenautsch2026,
author = {Mickenautsch, Steffen},
title = {Do nicotine inhaler increase smoking cessation during pregnancy?},
journal = {Knowledge Commons (Lakehead University)},
year = {2026},
doi = {10.17613/cb6bd-fn155}
}
EUVIMED